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Previous studies of the relationship between cigarette smoking and non-Hodgkin lymphoma (NHL) have yielded conflicting results,
perhaps because most studies have evaluated the risk for all NHL subtypes combined. Data from a population-based case–control
study conducted among women in Connecticut were used to evaluate the impact of cigarette smoking on the risk of NHL by
histologic type, tumour grade, and immunologic type. A total of 601 histologically confirmed, incident cases of NHL and 718
population-based controls provided in-person interviews. A standardised, structured questionnaire was used to collect information
on each subject’s current smoking status, age at initiation, duration and intensity of smoking, and cumulative lifetime exposure to
smoking. Our data suggest that cigarette smoking does not alter the risk of all NHL subtypes combined. However, increased risk of
follicular lymphoma appears to be associated with increased intensity and duration of smoking, and cumulative lifetime exposure to
smoking. Compared with nonsmokers, women with a cumulative lifetime exposure of 16–33 pack-years and 34 pack-years or
greater experience 50% increased risk (OR¼1.5, 95% CI 0.9–2.5) and 80% increased risk (OR¼1.8, 95% CI 1.1–3.2), respectively,
of follicular lymphoma (P for linear trend¼0.05). Our study findings are consistent with several previous epidemiologic studies
suggesting that cigarette smoking increases the risk of follicular lymphoma. This research highlights the importance of distinguishing
between NHL subtypes in future research on the aetiology of NHL.
British Journal of Cancer (2003) 89, 2087–2092. doi:10.1038/sj.bjc.6601388 www.bjcancer.com
& 2003 Cancer Research UK
Keywords: lymphoma; non-Hodgkin; smoking; women; case–control studies
                                                     
Over the past several decades, incidence rates of non-Hodgkin
lymphoma (NHL) have increased dramatically in the United States
and throughout the world (Hartge et al, 1994; Bray et al, 2001;
Clarke and Glaser, 2002). The annual age-adjusted incidence rate
of NHL in the US per 100000 persons rose from 8.9 in 1973 to 15.6
in 1999 (Ries et al, 2002). Despite this observed increase in NHL
incidence and the intensification of epidemiologic investigations
into the aetiology of NHL, few concrete risk factors have been
identified for NHL.
Cigarette smoking has been proposed as one factor that could
potentially increase the risk of NHL, although epidemiologic
investigations of smoking and NHL have yielded conflicting results
(Magnani et al, 1990; Brown et al, 1992; Linet et al, 1992; Tavani
et al, 1994; Nelson et al, 1997; Zahm et al, 1997; Adami et al, 1998;
De Stefani et al, 1998; Freedman et al, 1998; Herrinton and
Friedman, 1998; Holly et al, 1999; Miligi et al, 1999; Grant, 2000;
Parker et al, 2000; Fabbro-Peray et al, 2001; Peach and Barnett,
2001; Stagnaro et al, 2001; Besson et al, 2003). Three studies have
reported a statistically significant increased risk of NHL among
smokers (Magnani et al, 1990; Linet et al, 1992; Freedman et al,
1998), while eight studies have reported no association or a weak
association between cigarette smoking and NHL (Tavani et al,
1994; Nelson et al, 1997; Adami et al, 1998; De Stefani et al, 1998;
Holly et al, 1999; Miligi et al, 1999; Grant, 2000; Fabbro-Peray et al,
2001).
A potential limitation of most previous studies of cigarette
smoking and NHL may be that they have failed to investigate the
effect of smoking by NHL subtype. Descriptive epidemiologic
studies have shown that the magnitude of incidence rates and the
recent changes in incidence rates vary for different NHL subtypes
(Groves et al, 2000). Analytical epidemiologic studies have also
shown that risk associated with various potential risk factors for
NHL, such as pesticides, solvents, hair dye, and viruses, may vary
by NHL subtype (Weisenburger, 1994; Germanidis et al, 1999;
Shariff et al, 1999; Waddell et al, 2001; Zheng et al, 2002; Zhang
et al, in press). Earlier epidemiologic studies of smoking and NHL
that have considered the association between cigarette smoking
and NHL have also suggested that the relationship may vary by
histologic subtype of NHL (Herrinton and Friedman, 1998; Parker
et al, 2000; Stagnaro et al, 2001; Besson et al, 2003). Thus,
evaluation of the potential impact of cigarette smoking on NHL by
disease subtype appears to be necessary.
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population-based case–control study among 1319 Connecticut
women was used to investigate the a priori hypothesis that
smoking increases the risk of NHL, and that this increased risk
varies by NHL histologic type, tumour grade, and immunologic
type. The current status of smoking, age at initiation, duration and
intensity of smoking, and cumulative lifetime exposure to smoking
were compared between cases and controls to estimate the risk
these factors confer on NHL and NHL subtypes.
MATERIALS AND METHODS
Study population
Detailed information on the study population and data collection
for this study has been published elsewhere (Morton et al,i n
press). Briefly, a total of 1319 female residents of Connecticut, who
were between the ages of 21 and 84 years, had no previous
diagnosis of cancer (except nonmelanoma skin cancer), and were
alive at the time of interview were recruited for this population-
based case–control study from 1995 to 2001. The Yale Compre-
hensive Cancer Center’s Rapid Case Ascertainment Shared
Resource (RCA), a component of the Connecticut Tumor Registry
(CTR), was used to identify incident cases of NHL (ICD-O, M-
9590-9642, 9690-9701, 9740-9750). A total of 1122 potential NHL
cases were identified, of which 290 were judged to be ineligible for
this study (167 died before they could be interviewed, and 123 were
excluded for other reasons, such as previous diagnosis of cancer,
unable to speak English, or physician refusal). Thus, a total of 832
incident, eligible cases of NHL were contacted for participation in
this study, and 601 (72%) of these cases completed in-person
interviews. The median time between diagnosis and interview for
cases was 2.5 months. Two study pathologists (Drs Flynn, Tallini)
independently reviewed the tissue samples for all cases to confirm
the diagnosis of NHL and classify NHL cases according to the
Working Formulation into histologic type (diffuse, follicular,
other), tumour grade (low, intermediate, high, other), and
immunologic type (B-cell, T-cell, other). Tissue samples receiving
conflicting classifications were re-evaluated until a consensus was
reached.
A population-based control group, consisting of 718 women
who completed in-person interviews, was assembled using two
methods. Random digit dialing was used to recruit women less
than 65 years of age; including the initial telephone screening,
69% of the women contacted using random digit dialing completed
in-person interviews. Women 65 years of age and older were
selected randomly from the files of the Centers for Medicare and
Medicaid Services; 47% of the women contacted from these files
completed in-person interviews. The number of controls that were
randomly selected within each age stratum was adjusted every few
months in order to frequency match cases and controls by age in
5-year groups. A total of 718 controls completed in-person
interviews.
Data collection
This study was conducted based on a protocol approved by the
Human Investigations Committees at Yale University and the
Connecticut Department of Health, and an Institutional Review
Board of the National Cancer Institute. Cases were contacted first
by letter and then by telephone, only after approval by each
subject’s physician. Controls were contacted after selection
through random sampling. Trained interviewers administered a
standardised, structured questionnaire to subjects who agreed to
participate. During the interview, respondents were asked about
their smoking history and other known or suspected risk factors
for NHL.
Subjects were classified as never smokers if they had never
smoked at least 100 cigarettes prior to 1 year before the interview.
Respondents who had smoked at least 100 cigarettes were further
questioned as to the age they began smoking, the average number
of cigarettes smoked per day, the number of years during which
they smoked at least one cigarette per day, whether they had
stopped smoking in the past year, and the age at which they
stopped smoking. Additional information on age, height, usual
weight, education, race, alcohol use, menopausal status, family
history of cancer, and other factors was also obtained during the
interview. Continuous demographic variables and potential con-
founding factors were categorised a priori, based on previous
cutpoints used in the literature or the distribution among control
subjects.
Statistical analysis
Statistical analyses for this study were performed using the SAS
system, version 8.02. (SAS Institute Inc., Cary, NC, USA).
Unconditional logistic regression models were developed
using data on smoking history, in order to predict the risk of
NHL and NHL subtypes (Breslow and Day, 1980). Subjects
who reported smoking less than a total of 100 cigarettes in their
lifetime were classified as never smokers, and were used
as the reference group for all analyses. Ever smokers were
further categorised as current or former smokers, based on their
smoking status at the time of the interview. Data on the
duration and intensity of smoking were integrated to create a
single measure (pack-years¼number of packs smoked per day
times number of years smoked), in order to estimate the
cumulative lifetime exposure to cigarette smoking. Continuous
predictor variables, including age started smoking, duration of
smoking, number of cigarettes smoked per day, and pack-years,
were categorised into tertiles or quartiles a priori, based on
previous cutpoints used in the literature or the distribution among
control subjects.
Age, race, family history of cancer, education, body-mass index
(BMI), alcohol use, and menopausal status were considered as
potential confounding factors for this analysis. The associations of
potential confounding factors with smoking predictor variables
and NHL subtypes were assessed using Pearson’s w
2 statistic. Wald
w
2 statistics were calculated for each potential confounder in the
multivariate models to test the null hypothesis that each covariate
had no effect on the outcome, given that the other variables were
already in the model. Decisions on which covariates to include in
the final model were based on a Wald w
2 statistic with Po0.2 and a
greater than 10% change in the risk estimates for at least some
NHL subtypes. The final estimates of the risk of NHL and NHL
subtypes using the smoking predictor variables were adjusted for
age (o50, 50–70, 470 years), race (white, other), family history
of cancer (any cancer, none), education (high school or less, some
college, college graduate or more), BMI (o25, 25–29.99,
X30kgm
 2), alcohol use (ever, never), and menopausal status
(premenopausal, postmenopausal). Adjusted odds ratios (OR) and
95% confidence intervals (95% CI) were calculated using multi-
variate unconditional logistic regression models. Tests for linear
trend were conducted by including smoking predictor variables as
continuous variables in the multivariate unconditional logistic
regression models.
RESULTS
The selected demographic characteristics of cases and controls
were compared (Table 1). Owing to the frequency matching by age
strata, cases and controls were similar with respect to age. The
distribution of race and reported family history of cancer were also
similar among cases and controls. For all NHL cases combined and
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less highly educated and have a higher BMI than controls
(Po0.05). In addition, fewer cases than controls reported ever
having consumed alcohol (Po0.05).
Table 2 presents the risk of NHL by smoking for all NHL
subtypes combined. When compared to women who have never
smoked, the risk of NHL did not appear to be significantly altered
by current or former smoking status, the age subjects began
smoking, the number of cigarettes smoked per day, the duration of
smoking, or the cumulative lifetime exposure to smoking (Table 2).
Further analysis by NHL subtype, however, suggests that the risk
of follicular lymphoma may be elevated by increased duration of
smoking and cumulative lifetime exposure to smoking (Table 3).
Compared with nonsmokers, women with a cumulative lifetime
exposure of 16–33 pack-years and 34 pack-years or greater
experience 50% increased risk (OR¼1.5, 95% CI 0.9–2.5) and 80%
increased risk (OR¼1.8, 95% CI 1.1–3.2), respectively, illustrating
a dose–response relationship between cumulative lifetime ex-
posure and follicular lymphoma (P for linear trend¼0.05). Our
data fail to show clear relationships with the intensity of smoking,
the age subjects began smoking, and current smoking status,
although this is not surprising given the small number of cases
examined if the relationship with smoking is weak. Stratification
by age for those aged less than 65 years or 65 years and over
showed similar results.
Smoking history does not appear to alter the risk of NHL by
tumour grade (low, medium, high) or for B-cell lymphomas
(Table 3). There is a suggestion of an association for T-cell
lymphomas; however, the number of cases was too small to
conclusively assess the impact of smoking. Smoking did not
significantly alter the risk of NHL for other histologic types,
tumour grades, and immunologic types, as classified by the
Working Formulation (data not shown).
DISCUSSION
In this population-based case–control study, we found that
smoking appeared to increase the risk of follicular lymphoma,
and that this risk increased with increased duration and pack-
years of cigarette smoking. Smoking did not appear to play a role
in other histologic types of NHL.
Our results are consistent with previous epidemiologic studies
that also considered the relationship between cigarette smoking
and NHL by histologic subtype, and that found an increased risk
among smokers for follicular lymphoma, but not for diffuse
lymphoma (Herrinton and Friedman, 1998; Parker et al, 2000;
Stagnaro et al, 2001; Besson et al, 2003). In a population-based
case–control study conducted in Italy, smoking was associated
with increased risk of follicular lymphoma, particularly among
women (Stagnaro et al, 2001). That study reported approximately
two-fold increased risk among women with the longest duration of
smoking; however, the trend for intensity of smoking was less
clear, and the impact of cumulative lifetime exposure to cigarette
smoking was not evaluated. A hospital-based case–control study
among men and women in France suggested a three-fold increase
in the risk of follicular NHL among current smokers, although the
result was not statistically significant, perhaps due to the small
sample size (Besson et al, 2003). Two cohort studies, the Iowa
Women’s Health Study (Parker et al, 2000) and a cohort study of
men and women from California (Herrinton and Friedman, 1998),
also have reported approximately two-fold increased risk of
follicular lymphoma among smokers compared to nonsmokers,
Table 1 Selected characteristics of NHL cases and controls among
women from Connecticut
Percent of cases
(n¼601)
Percent of controls
(n¼718)
Age (years)
p45 12.3 15.9
46–55 19.3 18.9
56–65 20.6 19.9
66–75 28.6 25.9
X76 19.1 19.4
Race
White 95.3 94.3
Other 4.7 5.7
Family history
None 21.5 24.9
Any Cancer 78.5 75.1
Education
High school or less 43.4 37.0
Some college 32.9 30.8
College graduate or more 23.6 32.2
BMI (kgm
 2)
o25 49.8 56.5
25–29.99 31.6 27.9
X30 18.6 15.6
Alcohol use
Never 38.3 32.5
Ever 61.7 67.5
Table 2 Risk of NHL associated with cigarette smoking for all NHL cases
combined
Cases Controls
## O R
a 95% CI
Smoking
Never 270 323 1.0
Ever 331 395 1.0 (0.8, 1.3)
Current 77 106 0.9 (0.6, 1.2)
Former 254 289 1.1 (0.8, 1.4)
Age at initiation (years)
p15 74 89 1.0 (0.7, 1.5)
16–19 163 187 1.1 (0.8, 1.4)
X20 94 119 1.0 (0.7, 1.3)
P for linear trend 0.97
Intensity (# cig/day)
1–10 73 100 1.0 (0.7, 1.3)
11–15 83 104 1.0 (0.7, 1.4)
16–20 119 135 1.0 (0.8, 1.4)
420 56 56 1.2 (0.8, 1.7)
P for linear trend 0.32
Duration (years)
1–10 50 72 0.9 (0.6, 1.4)
11–20 62 90 0.9 (0.6, 1.3)
21–30 69 80 1.0 (0.7, 1.5)
430 150 153 1.2 (0.9, 1.5)
P for linear trend 0.45
Pack-years
1–7 81 103 1.0 (0.7, 1.5)
8–14 53 95 0.7 (0.5, 1.0)
15–33 94 104 1.1 (0.8, 1.5)
X34 103 93 1.3 (0.9, 1.8)
P for linear trend 0.18
aAdjusted for age, race, family history of any cancer, education, BMI, previous alcohol
use, and menopausal status.
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and the three studies discussed above all found that a history of
cigarette smoking is associated with an approximately two-fold or
greater increased risk of follicular lymphoma when compared to
nonsmokers, but no relationship was found between smoking and
other NHL subtypes.
Previous studies that did not investigate the relationship
between smoking and NHL by histologic subtype may not have
found a relationship because smoking seems to increase only the
risk of follicular lymphoma, but not other NHL subtypes. If we had
not stratified by histologic type, the results of this study would
have been consistent with previous studies that did not stratify and
showed no effect.
It is not clear why the relationship between smoking and NHL
only exists for follicular lymphoma and not for other subtypes of
NHL. The mechanism of follicular lymphoma development among
cigarette smokers is not known. Studies have shown that
approximately 80–90% of follicular lymphomas, regardless of cell
type, are positive for t(14;18) translocation (Cleary et al, 1986a,b).
This somatic mutation joins the bcl-2 gene on chromosome 18 to
the immunoglobulin heavy chain gene on chromosome 14,
increasing the production of bcl-2 protein, which is involved in
the inhibition of apoptosis (Cleary et al, 1986a,b). Since these
mutations are likely to be the result of a direct carcinogenic effect,
rather than being related to immune suppression, it is possible that
the carcinogenic compounds in cigarettes could play a role in these
mutations. A recent case–control study of NHL that classified
cases by this mutation suggested a potential increased risk among
cigarette smokers for t(14;18)-positive NHL but not for t(14;18)-
negative NHL, although no clear trend was observed (Schroeder
et al, 2002). Additional studies considering the role of this
mutation could help to elucidate the role of cigarette smoking in
the development of follicular lymphomas.
A number of strengths and limitations of this study should be
considered in the interpretation of the results. In this large,
population-based case–control study, trained interviewers used
in-person, standardised, and structured interviews to minimise the
information bias resulting from exposure misclassification.
Incident cases were histologically confirmed and categorised
according to the Working Formulation, in order to minimise the
information bias resulting from disease misclassification. In
addition, subjects were asked standard, detailed questions with
respect to their smoking history, so that the smoking status, the
age subjects began smoking, the intensity and duration of
smoking, and the lifetime cumulative exposure to cigarette smoke
could be evaluated separately to understand which aspect of
cigarette smoking, if any, affects the risk of NHL and NHL
subtypes. Despite the relatively large size of this study, however,
stratification limited our ability to estimate the impact of smoking
on the risk of high-grade tumours and T-cell lymphomas, which
account for only a small proportion of lymphomas. In addition,
this analysis only addresses the potential relationship between
smoking and NHL for women, because one of the main objectives
of this population-based case–control study was to investigate the
Table 3 Risk of NHL associated with cigarette smoking for NHL subtypes
Histologic type Tumor grade Immunologic type
Diffuse (n¼346) Follicular (n¼134) Low (n¼177) Intermediate (n¼286) High (n¼18) B cell (n¼473) T cell (n¼44)
OR
a 95% CI OR
a 95% CI OR
a 95% CI OR
a 95% CI OR
a 95% CI OR
a 95% CI OR
a 95% CI
Smoking
Never 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Ever 1.0 (0.7, 1.3) 1.2 (0.8, 1.8) 1.1 (0.8, 1.6) 1.0 (0.7, 1.3) 1.0 (0.4, 2.7) 1.0 (0.8, 1.3) 1.2 (0.6, 2.3)
Current 0.7 (0.4, 1.1) 1.6 (0.9, 2.8) 1.1 (0.6, 1.9) 0.8 (0.5, 1.3) 1.1 (0.2, 6.3) 0.9 (0.6, 1.3) 0.9 (0.3, 2.5)
Former 1.1 (0.8, 1.4) 1.2 (0.8, 1.8) 1.1 (0.8, 1.6) 1.1 (0.8, 1.5) 0.9 (0.3, 2.8) 1.1 (0.8, 1.4) 1.3 (0.6, 2.5)
Age at initiation (years)
p15 1.1 (0.6, 1.6) 1.1 (0.6, 2.0) 0.8 (0.4, 1.5) 1.2 (0.8, 1.9) 1.8 (0.5, 6.6) 1.0 (0.7, 1.4) 1.6 (0.7, 4.1)
16–19 0.9 (0.7, 1.3) 1.5 (0.9, 2.4) 1.3 (0.9, 2.0) 1.0 (0.7, 1.4) 0.7 (0.2, 2.8) 1.1 (0.8, 1.5) 0.9 (0.4, 2.1)
X20 0.9 (0.6, 1.4) 1.0 (0.6, 1.8) 1.1 (0.6, 1.7) 0.9 (0.6, 1.4) 0.9 (0.2, 4.2) 1.0 (0.7, 1.4) 1.3 (0.6, 3.2)
P for linear trend 0.50 0.31 0.60 0.67 0.75 0.98 0.92
Intensity (#cig/day)
1–10 1.0 (0.7, 1.6) 0.6 (0.3, 1.3) 0.9 (0.5, 1.6) 0.9 (0.6, 1.5) 0.4 (0.1, 3.8) 0.9 (0.6, 1.3) 2.0 (0.7, 4.1)
11–15 0.9 (0.6, 1.3) 1.4 (0.8, 2.4) 1.2 (0.7, 1.9) 0.9 (0.6, 1.4) 1.5 (0.4, 6.1) 1.0 (0.7, 1.4) 0.9 (0.3, 2.6)
16–20 0.9 (0.7, 1.4) 1.7 (1.1, 2.7) 1.3 (0.9, 2.1) 1.0 (0.7, 1.5) 0.9 (0.2, 3.5) 1.2 (0.8, 1.6) 0.5 (0.2, 1.6)
420 1.1 (0.7, 1.8) 0.9 (0.4, 2.0) 0.9 (0.4, 1.7) 1.2 (0.7, 1.9) 1.5 (0.3, 7.7) 1.0 (0.6, 1.6) 2.4 (1.0, 5.9)
P for linear trend 0.65 0.16 0.34 0.52 0.51 0.43 0.44
Duration (years)
1–10 1.1 (0.7, 1.8) 0.8 (0.4, 1.7) 0.8 (0.4, 1.5) 1.2 (0.7, 1.9) 1.0 (0.2, 5.2) 0.9 (0.6, 1.5) 0.8 (0.2, 2.8)
11–20 0.8 (0.5, 1.3) 0.9 (0.5, 1.8) 0.9 (0.5, 1.6) 0.8 (0.5, 1.4) 0.4 (0.1, 3.7) 0.9 (0.6, 1.4) 0.6 (0.2, 2.0)
21–30 0.9 (0.6, 1.4) 1.1 (0.6, 2.0) 1.1 (0.6, 1.9) 0.8 (0.5, 1.3) 0.9 (0.2, 4.6) 1.0 (0.6, 1.4) 1.6 (0.6, 4.0)
430 1.0 (0.7, 1.4) 1.8 (1.1, 2.8) 1.4 (0.9, 2.1) 1.1 (0.8, 1.6) 1.6 (0.4, 5.9) 1.2 (0.8, 1.6) 1.6 (0.7, 3.7)
P for linear trend 0.91 0.06 0.27 0.78 0.56 0.55 0.32
Pack-years
1–7 1.1 (0.7, 1.7) 0.9 (0.5, 1.7) 1.0 (0.6, 1.7) 1.1 (0.7, 1.7) 0.8 (0.2, 3.8) 1.1 (0.8, 1.6) 0.8 (0.3, 2.4)
8–14 0.6 (0.4, 1.0) 0.8 (0.4, 1.5) 0.9 (0.5, 1.5) 0.6 (0.3, 1.0) 0.4 (0.1, 3.7) 0.7 (0.4, 1.0) 1.2 (0.4, 3.1)
15–33 1.0 (0.7, 1.5) 1.5 (0.9, 2.5) 1.2 (0.7, 2.0) 1.1 (0.7, 1.6) 1.8 (0.5, 6.2) 1.1 (0.7, 1.5) 1.6 (0.7, 3.7)
X34 1.1 (0.7, 1.6) 1.8 (1.1, 3.2) 1.4 (0.9, 2.3) 1.3 (0.8, 1.9) 1.1 (0.2, 5.6) 1.3 (0.9, 1.8) 1.2 (0.5, 3.3)
P for linear trend 0.66 0.05 0.28 0.44 0.09 0.31 0.31
aAdjusted for age, race, family history of any cancer, education, BMI, previous alcohol use, and menopausal status.
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and menarche and risk of NHL in Connecticut women.
Although this study was population-based, the relatively low
participation rates among potential population controls, especially
among women 65 years of age and older, recruited from the files of
the Centers of Medicare and Medicaid Services, are of possible
concern. However, the association between smoking and disease
was observed only among women with follicular lymphomas and
not other NHL subtypes. In addition, stratification by age for
those aged less than 65 years or 65 years and over showed similar
results. Therefore, it is unlikely that selection bias can explain the
observed associations. Self-report of smoking history has been
shown to be reliable and accurate, based on comparisons of self-
reported data to biochemical markers of tobacco exposure (Patrick
et al, 1994). Therefore, it is unlikely that the observed result is due
to recall bias. The hypothesised relationship between smoking and
NHL is not well known; therefore it is unlikely that the observed
result is due to reporting bias. In addition, the elevated risk of
follicular lymphoma is unlikely to be the result of recall or
reporting bias because the association is not observed across all
NHL subtypes.
In summary, this population-based case–control study supports
the hypothesis that increased pack-years and duration of smoking
result in an elevated risk of follicular lymphoma, but do not alter
the risk for other NHL subtypes. The results of this study highlight
the need to distinguish between NHL histologic subtypes in future
research on the aetiology of NHL.
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